United Therapeutics
UTHR
UTHR
373 hedge funds and large institutions have $4.88B invested in United Therapeutics in 2018 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 128 increasing their positions, 154 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $6.44B → $4.88B (-$1.56B)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
37% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 52
Holders
373
Holding in Top 10
4
Calls
$22.3M
Puts
$22.8M
Top Buyers
| 1 | +$63.7M | |
| 2 | +$40.4M | |
| 3 | +$25.6M | |
| 4 |
AC
Armistice Capital
New York
|
+$21.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.4M |
Top Sellers
| 1 | -$53.7M | |
| 2 | -$33.2M | |
| 3 | -$32.5M | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$22.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$21.2M |